Announces Q3 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Management Discussion & Analysis & Results Press Release for the Quarter ended December 31, 2016

• Security Code: 532296
• Company: GLENMARK

Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2016:

The Un-audited Standalone results for the Quarter ended December 31, 2016

The Company has posted a net profit of Rs. 7113.07 million for the quarter ended December 31, 2016 as compared to Rs. 2631.76 million for the quarter ended December 31, 2015. Total Income has increased from Rs. 14132.80 million for the quarter ended December 31, 2015 to Rs. 22981.37 million for the quarter ended December 31, 2016.

The Consolidated Results are as follows:

The Un-audited Consolidated results for the Quarter ended December 31, 2016

The Group has posted a net profit after tax, minority interest and share of profit of associates of Rs. 4770.30 million for the quarter ended December 31, 2016 as compared to Rs. 1961.77 million for the quarter ended December 31, 2015. Total Income has increased from Rs. 17804.33 million for the quarter ended December 31, 2015 to Rs. 25495.75 million for the quarter ended December 31, 2016.